Febuxostat

Back to search

Molecule Structure

Scientific Name

Febuxostat

Description of the Drug

Febuxostat is a xanthine oxidase inhibitor used for the management of chronic hyperuricemia in adults with gout who have an inadequate response or intolerance to allopurinol.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB04854

Brand Name(s)

Adenuric, Uloric

Company Owner(s)

Sunshine Lake Pharma Co Ltd, Alkem Laboratories Ltd, Msn Laboratories Private Ltd, Alembic Pharmaceuticals Ltd, Takeda Pharmaceuticals Usa Inc, Sun Pharmaceutical Industries Ltd, Dr Reddys Laboratories Ltd, Mylan Pharmaceuticals Inc, Hikma Pharmaceuticals Usa Inc, Prinston Pharmaceutical Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Xanthine dehydrogenase SINGLE PROTEIN INHIBITOR CHEMBL1929

Unichem Links

SureChEMBL SCHEMBL249339
Human Metabolome Database HMDB0252185
DrugBank DB04854
PubChem: Thomson Pharma 14899120
PubChem 134018
Mcule MCULE-6974079178
LINCS LSM-3064
Nikkaji J551.973J
PDBe TEI
BindingDB 50320491
EPA CompTox Dashboard DTXSID8048650
DrugCentral 1137
Brenda 92458
ChemicalBook CB4841564 CB22508843
Guide to Pharmacology 6817
rxnorm ULORIC FEBUXOSTAT
PubChem: Drugs of the Future 12014717
ChEBI 31596
ZINC ZINC000000005423